Widespread use of Ozempic for weight loss could change how we view fatness
Don’t Call Me Resilient - A podcast by The Conversation, Vinita Srivastava, Dannielle Piper, Krish Dineshkumar, Jennifer Moroz, Rehmatullah Sheikh, Kikachi Memeh, Ateqah Khaki, Scott White
Categories:
In this episode of Don't Call Me Resilient, we are joined by fat and disability studies professor Fady Shanouda, who examines anti-fat bias in medicine. As the use of Ozempic, a drug for diabetes, slams into the mainstream as a weight-loss method, will the drug’s use impact our concept of fatness? And how does fatness intersect with race and class?
